BioLight Announces Partnership with Axella Research for CellDetect® Non-Invasive Test for Monitoring Recurrence of Bladder Cancer

BioLight announced today that its cancer diagnostics subsidiary, Micromedic Technologies, has entered into a Collaboration Agreement with Axella Research LLC, to advance the clinical and regulatory efforts required to commercialize the CellDetect® non-invasive diagnostic test for the monitoring of bladder cancer recurrence in the United States.

Link to the complete article

Link to Newsroom

Comments are closed.